Superactive human leptin antagonist (SHLA), triple Lan1 and quadruple Lan2 leptin mutein as a promising treatment for human folliculoma
Crossref DOI link: https://doi.org/10.1007/s00280-017-3423-5
Published Online: 2017-08-31
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fiedor, E.
Gregoraszczuk, E. L.
License valid from 2017-08-31